AC Immune S.A.
General ticker "ACIU" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $294.5M (TTM average)
AC Immune S.A. does not follow the US Stock Market performance with the rate: -15.9%.
Estimated limits based on current volatility of 1.7%: low 2.35$, high 2.43$
Factors to consider:
- Total employees count: 122 (-29.1%) as of 2025
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.45$, 5.39$]
- 2026-12-31 to 2027-12-31 estimated range: [2.50$, 5.41$]
Financial Metrics affecting the ACIU estimates:
- Positive: with PPE of -3.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: 25.20 < Shareholder equity ratio, % of 29.10 <= 34.41
- Positive: Inventory ratio change, % of -95.91 <= -3.92
- Positive: Interest expense per share per price, % of 0.08 <= 0.33
- Positive: Investing cash flow per share per price, % of 24.06 > 2.08
Short-term ACIU quotes
Long-term ACIU plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CHF14.80MM | CHF27.31MM | CHF3.57MM |
| Operating Expenses | CHF68.42MM | CHF79.69MM | CHF72.44MM |
| Operating Income | CHF-53.62MM | CHF-52.38MM | CHF-68.86MM |
| Non-Operating Income | CHF-0.60MM | CHF1.47MM | CHF-1.58MM |
| Interest Expense | CHF0.18MM | CHF0.13MM | CHF0.19MM |
| R&D Expense | CHF54.61MM | CHF62.57MM | CHF56.44MM |
| Income(Loss) | CHF-54.22MM | CHF-50.91MM | CHF-70.45MM |
| Taxes | CHF0.01MM | CHF0.00MM | CHF0.00MM |
| Net Income(Loss)* | CHF-54.23MM | CHF-50.92MM | CHF-73.61MM |
| Stockholders Equity | CHF160.64MM | CHF112.27MM | CHF44.93MM |
| Assets | CHF182.81MM | CHF230.91MM | CHF154.43MM |
| Operating Cash Flow | CHF-60.41MM | CHF65.84MM | CHF-66.15MM |
| Capital expenditure | CHF0.80MM | CHF0.58MM | CHF0.86MM |
| Investing Cash Flow | CHF65.64MM | CHF-105.29MM | CHF60.69MM |
| Financing Cash Flow | CHF43.25MM | CHF-1.12MM | CHF-0.97MM |
| Earnings Per Share** | CHF-0.64 | CHF-0.51 | CHF-0.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.